Patent ID: 6939970

Claim:
Monohydrated form C of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid having a powder X-ray diffraction pattern Multiplicity Lattice spacing 2θ h k l factor J (Å) “mean λ CuKα ” 1.54184 Å 1 1 0 4 10.0418 8.8058 2 0 0 2 10.0112 8.8327 1 0 1 4 9.6580 9.1564 0 1 1 4 7.9939 11.0679 2 1 0 4 7.5809 11.6729 1 1 1 8 7.4241 11.9204 2 0 1 4 7.4117 11.9404 2 1 1 8 6.2468 14.1776 0 2 0 2 5.8035 15.2666 3 1 0 4 5.7858 15.3136 3 0 1 4 5.7095 15.5195 1 2 0 4 5.5741 15.8990 0 0 2 2 5.5128 16.0771 1 0 2 4 5.3150 16.6795 0 2 1 4 5.1355 17.2667 3 1 1 8 5.1233 17.3084 2 2 0 4 5.0209 17.6641 4 0 0 2 5.0056 17.7185 0 1 2 4 4.9796 17.8116 1 2 1 8 4.9745 17.8301 1 1 2 8 4.8324 18.3588 2 0 2 4 4.8290 18.3719 4 1 0 4 4.5964 19.3104 2 2 1 8 4.5694 19.4256 4 0 1 4 4.5579 19.4752 2 1 2 8 4.4585 19.9134 3 2 0 4 4.3794 20.2770 3 0 2 4 4.2503 20.8996 4 1 1 8 4.2425 20.9387 3 2 1 8 4.0701 21.8363 at 295 K expressed in terms of h, k, l, multiplicity factor J, lattice spacing in Å and 2θ.